Intensity-modulated radiation therapy for pediatric medulloblastoma: Early report on the reduction of ototoxicity
Disclosures: Daniel Yan Zheng Lim: Nothing to Disclose, Siyuan Yin: Nothing to Disclose, Charlene Tan Hui Ru: Nothing to Disclose, Jeanette Ng: Nothing to Disclose, Chee-Kiat Tan: Eisai: Advisor, Abbott Laboratories: Advisor, Gilead Sciences: Advisor, Roche Diagnostics: Advisor, Fujifilm: Advisor, George Boon Bee Goh: Nothing to Disclose 2066 MULTIPLEXED IN VIVO SCREENING REVEALS THE DELETERIOUS EFFECTS OF FIBROGENIC FACTORS ON HEPATOCYTES Joanne Hsieh 1 Vinay Kartha 1 Hikaru Miyazaki 1 Christopher Carrico 1 Linda Chio 1 Daniel Fuentes 1 Dimitry Popov 1 Ian Driver 1 Chris Towne 1 Francisco LePort 1 Martin Borch Jensen 1 , 1 Gordian Biotechnology Background: Hepatocyte injury and death promotes fibrosis deposition, but the ramifications of extracellular matrix composition on hepatocytes is less understood
The publisher's commercial relationship with altRx is disclosed in good faith in compliance with FTC guidelines on endorsements and testimonials
Help Keep Our Community Safe To create a safe place, please be respectful and kind be open-minded to other opinions think twice before sharing personal details foster a friendly and supportive environment remove fake accounts, spam and misinformation delete posts that violate our community guidelines
Development of otoconia